Salute e Benessere
Digital Migraine Treatment Devices Market to Reach USD 298.71 Million by 2030, Fueled by Non-Invasive Neuromodulation and Expanding Clinical Adoption | DataM Intelligence
as clinicians prescribe devices alongside standard migraine care. , focused on neurology and pain management, contributed , reflecting growing physician confidence in device efficacy. (including telemedicine channels and direct-to-consumer models) generated but are expected to expand rapidly with the rise of digital health adoption.
The U.S., valued at , dominates the global market due to:
Japan's market, valued at , is expanding at a faster pace relative to other Asia-Pacific nations. Growth drivers include:
The pioneer in supraorbital stimulation devices, Cefaly reported Its strong brand recognition and recent integration with smartphone platforms make it the market leader in digital migraine therapy.
ElectroCore's generated , with FDA clearances for multiple headache disorders. In 2025, it expanded into telemedicine partnerships to improve distribution in rural U.S. markets.
Focused on , eNeura generated The company is exploring partnerships with Japanese hospitals to strengthen its Asia-Pacific footprint.
Theranica's achieved strong adoption, with Its app-based platform and AI integration differentiate it as a next-gen digital therapy.
These firms are advancing breakthrough devices in with several late-stage clinical trials underway in 2025. Their progress could expand the therapeutic arsenal in migraine management.
The is set for rapid expansion over the next decade. The market's growth trajectory highlights three defining imperatives:
The global , projected to rise from , reflects a decisive shift toward With the U.S. driving clinical adoption and Japan setting innovation benchmarks in Asia , stakeholders across medtech, digital health, and investment ecosystems have a compelling growth opportunity.
https://www.datamintelligence.com/reports-subscription
– From R&D, Investment, to marketing strategies, track your global and regional rivals with ease.
– Stay ahead with detailed company profiling, SWOT analyses, and sales performance tracking.
– Daily alerts keep teams informed about product innovation, M&A activity, and competitor moves.
– Access the complete library of market reports across geographies.
– Get specific segments or competitor data added without paying extra.
– Get detailed views of market trends across the U.S., EU5, Japan , India , and LATAM.
– Make informed decisions using real-time trade intelligence.
:
Mr. Sai Kiran
DataM Intelligence 4market Research LLP Ground floor
DSL Abacus IT Park, Industrial Development Area
Uppal, Hyderabad , Telangana 500039
+1 877-441-4866
: Sai.k@datamintelligence.com
Logo: https://mma.prnewswire.com/media/1858619/3573087/DataM_Intelligence_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/digital-migraine-treatment-devices-market-to-reach-usd-298-71-million-by-2030--fueled-by-non-invasive-neuromodulation-and-expanding-clinical-adoption--datam-intelligence-302565809.html